Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease
There is an urgent need for early biomarkers and novel disease-modifying therapies in
Huntington's disease. Huntington's disease pathology involves the toxic effect of mutant …
Huntington's disease. Huntington's disease pathology involves the toxic effect of mutant …
Coexistence of gait disturbances and chorea in experimental Huntington's disease
J Casaca-Carreira, Y Temel, M Van Zelst… - Behavioural …, 2015 - Wiley Online Library
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by
an expanded CAG repeat. The clinical features are progressive motor dysfunction, cognitive …
an expanded CAG repeat. The clinical features are progressive motor dysfunction, cognitive …
[HTML][HTML] The clinical utility of multidisciplinary rehabilitation in individuals with Huntington's Disease
TM Cruickshank - 2015 - ro.ecu.edu.au
Background Huntington's disease (HD) is a chronic neurodegenerative disorder
characterised by a progressive loss of cognitive function, motor control and psychiatric …
characterised by a progressive loss of cognitive function, motor control and psychiatric …